سماگلوتاید CAS:910463-68-2

Semaglutide(Ozempic) is a glucagon-like peptide-1 analogue for once-weekly subcutaneous treatment of type 2 diabetes.Semaglutide is a pharmaceutical drug which is used for the treatment of type 2 دیابت. Semaglutide has demonstrated the potential to improve the treatment of type 2 diabetes and the positive recommendation from the Advisory Committee marks an important step towards making semaglutide available to adults with type 2 diabetes in the US. Semaglutide(Ozempic), a newly once-weekly glucagon like peptide-1 (GLP-1) آگونیست گیرنده, has showed a favorable effect on glycaemic control and weight reduction in type 2 دیابت قندی (T2DM).

Semaglutide has a chemical structure that is very similar to the hormone glucagon-like peptide 1 (GLP-1), adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.Semaglutide may help people with obesity lose weight as well.